▶ 調査レポート

ムコ多糖症(MPS)遺伝子治療の世界市場(~2026年)

• 英文タイトル:Global Gene Therapy for Mucopolysaccharidosis Market Size, Status and Forecast 2020-2026

QYResearchが調査・発行した産業分析レポートです。ムコ多糖症(MPS)遺伝子治療の世界市場(~2026年) / Global Gene Therapy for Mucopolysaccharidosis Market Size, Status and Forecast 2020-2026 / MRC2-11QY12019資料のイメージです。• レポートコード:MRC2-11QY12019
• 出版社/出版日:QYResearch / 2020年11月25日
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、92ページ
• 納品方法:Eメール(納期:2~3日)
• 産業分類:ヘルスケア
• 販売価格(消費税別)
  Single User¥577,200 (USD3,900)▷ お問い合わせ
  Multi User¥865,800 (USD5,850)▷ お問い合わせ
  Enterprise License¥1,154,400 (USD7,800)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
当調査資料はムコ多糖症(MPS)遺伝子治療のグローバル市場について調査・分析したレポートです。種類別(静脈内、ICV、脳内、大槽内)市場規模、用途別(ムコ多糖症I型、ムコ多糖症II型、ムコ多糖症IIIA型、ムコ多糖症IIIB型)市場規模、地域別(北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等)市場規模データ、主な企業情報と企業別市場シェア等が収録されています。
・調査範囲
・エグゼクティブサマリー
・企業別ムコ多糖症(MPS)遺伝子治療の競争状況、市場シェア
・世界のムコ多糖症(MPS)遺伝子治療市場:種類別市場規模 2015年-2020年(静脈内、ICV、脳内、大槽内)
・世界のムコ多糖症(MPS)遺伝子治療市場:種類別市場規模予測 2021年-2026年(静脈内、ICV、脳内、大槽内)
・世界のムコ多糖症(MPS)遺伝子治療市場:用途別市場規模 2015年-2020年(ムコ多糖症I型、ムコ多糖症II型、ムコ多糖症IIIA型、ムコ多糖症IIIB型)
・世界のムコ多糖症(MPS)遺伝子治療市場:用途別市場規模予測 2021年-2026年(ムコ多糖症I型、ムコ多糖症II型、ムコ多糖症IIIA型、ムコ多糖症IIIB型)
・北米のムコ多糖症(MPS)遺伝子治療市場分析:米国、カナダ
・ヨーロッパのムコ多糖症(MPS)遺伝子治療市場分析:ドイツ、フランス、イギリス、イタリア、ロシア等
・アジアのムコ多糖症(MPS)遺伝子治療市場分析:日本、中国、韓国、インド、オーストラリア、台湾等
・中南米のムコ多糖症(MPS)遺伝子治療市場分析:メキシコ、ブラジル、アルゼンチン等
・中東・アフリカのムコ多糖症(MPS)遺伝子治療市場分析:トルコ、サウジアラビア、UAE等
・企業情報(企業概要、製品概要、販売量、企業動向)
- 掲載企業(変更可能性あり):Sangamo Therapeutics、Swedish Orphan Biovitrum、uniQure
・地域別市場規模予測(2021年-2026年):北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場
・市場機会、課題、リスク、環境分析
・バリューチェーン、販売チャネル分析
・調査の結論

Mucopolysaccharidosis consists of a group of more than 40 genetic disorders that forms a part of lysosomal storage disease. They are caused by an inherited deficiency of an enzyme involved in the degradation of acid glycosaminoglycans (GAGs), which was previously known as mucopolysaccharidosis. All of the mucopolysaccharidoses are rare, autosomal recessive, except for mucopolysaccharidosis III, as it is X-linked.
Over the past few years, gene therapy has emerged as one of the most exciting approaches for the treatment of mucopolysaccharidosis. One of the promising therapy is replacement gene therapy, which replaces faulty genes with normal ones in the body. It is considered to be a potential cure to mucopolysaccharidoses and a promising option in the long run.

Market Analysis and Insights: Global Gene Therapy for Mucopolysaccharidosis Market
The global Gene Therapy for Mucopolysaccharidosis market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.

Global Gene Therapy for Mucopolysaccharidosis Scope and Market Size
Gene Therapy for Mucopolysaccharidosis market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Gene Therapy for Mucopolysaccharidosis market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

The key players covered in this study
Sangamo Therapeutics
Swedish Orphan Biovitrum
uniQure

Market segment by Type, the product can be split into
Intravenous
ICV
Intracerebral
Intracisternal
Market segment by Application, split into
Mucopolysaccharidosis I
Mucopolysaccharidosis II
Mucopolysaccharidosis III A
Mucopolysaccharidosis III B

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Gene Therapy for Mucopolysaccharidosis Revenue
1.4 Market by Type
1.4.1 Global Gene Therapy for Mucopolysaccharidosis Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Intravenous
1.4.3 ICV
1.4.4 Intracerebral
1.4.5 Intracisternal
1.5 Market by Application
1.5.1 Global Gene Therapy for Mucopolysaccharidosis Market Share by Application: 2020 VS 2026
1.5.2 Mucopolysaccharidosis I
1.5.3 Mucopolysaccharidosis II
1.5.4 Mucopolysaccharidosis III A
1.5.5 Mucopolysaccharidosis III B
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Global Gene Therapy for Mucopolysaccharidosis Market Perspective (2015-2026)
2.2 Global Gene Therapy for Mucopolysaccharidosis Growth Trends by Regions
2.2.1 Gene Therapy for Mucopolysaccharidosis Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Gene Therapy for Mucopolysaccharidosis Historic Market Share by Regions (2015-2020)
2.2.3 Gene Therapy for Mucopolysaccharidosis Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Gene Therapy for Mucopolysaccharidosis Market Growth Strategy
2.3.6 Primary Interviews with Key Gene Therapy for Mucopolysaccharidosis Players (Opinion Leaders)

3 Competition Landscape by Key Players
3.1 Global Top Gene Therapy for Mucopolysaccharidosis Players by Market Size
3.1.1 Global Top Gene Therapy for Mucopolysaccharidosis Players by Revenue (2015-2020)
3.1.2 Global Gene Therapy for Mucopolysaccharidosis Revenue Market Share by Players (2015-2020)
3.1.3 Global Gene Therapy for Mucopolysaccharidosis Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Gene Therapy for Mucopolysaccharidosis Market Concentration Ratio
3.2.1 Global Gene Therapy for Mucopolysaccharidosis Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Gene Therapy for Mucopolysaccharidosis Revenue in 2019
3.3 Gene Therapy for Mucopolysaccharidosis Key Players Head office and Area Served
3.4 Key Players Gene Therapy for Mucopolysaccharidosis Product Solution and Service
3.5 Date of Enter into Gene Therapy for Mucopolysaccharidosis Market
3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Gene Therapy for Mucopolysaccharidosis Historic Market Size by Type (2015-2020)
4.2 Global Gene Therapy for Mucopolysaccharidosis Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)
5.1 Global Gene Therapy for Mucopolysaccharidosis Market Size by Application (2015-2020)
5.2 Global Gene Therapy for Mucopolysaccharidosis Forecasted Market Size by Application (2021-2026)

6 North America
6.1 North America Gene Therapy for Mucopolysaccharidosis Market Size (2015-2020)
6.2 Gene Therapy for Mucopolysaccharidosis Key Players in North America (2019-2020)
6.3 North America Gene Therapy for Mucopolysaccharidosis Market Size by Type (2015-2020)
6.4 North America Gene Therapy for Mucopolysaccharidosis Market Size by Application (2015-2020)

7 Europe
7.1 Europe Gene Therapy for Mucopolysaccharidosis Market Size (2015-2020)
7.2 Gene Therapy for Mucopolysaccharidosis Key Players in Europe (2019-2020)
7.3 Europe Gene Therapy for Mucopolysaccharidosis Market Size by Type (2015-2020)
7.4 Europe Gene Therapy for Mucopolysaccharidosis Market Size by Application (2015-2020)

8 China
8.1 China Gene Therapy for Mucopolysaccharidosis Market Size (2015-2020)
8.2 Gene Therapy for Mucopolysaccharidosis Key Players in China (2019-2020)
8.3 China Gene Therapy for Mucopolysaccharidosis Market Size by Type (2015-2020)
8.4 China Gene Therapy for Mucopolysaccharidosis Market Size by Application (2015-2020)

9 Japan
9.1 Japan Gene Therapy for Mucopolysaccharidosis Market Size (2015-2020)
9.2 Gene Therapy for Mucopolysaccharidosis Key Players in Japan (2019-2020)
9.3 Japan Gene Therapy for Mucopolysaccharidosis Market Size by Type (2015-2020)
9.4 Japan Gene Therapy for Mucopolysaccharidosis Market Size by Application (2015-2020)

10 Southeast Asia
10.1 Southeast Asia Gene Therapy for Mucopolysaccharidosis Market Size (2015-2020)
10.2 Gene Therapy for Mucopolysaccharidosis Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Gene Therapy for Mucopolysaccharidosis Market Size by Type (2015-2020)
10.4 Southeast Asia Gene Therapy for Mucopolysaccharidosis Market Size by Application (2015-2020)

11 India
11.1 India Gene Therapy for Mucopolysaccharidosis Market Size (2015-2020)
11.2 Gene Therapy for Mucopolysaccharidosis Key Players in India (2019-2020)
11.3 India Gene Therapy for Mucopolysaccharidosis Market Size by Type (2015-2020)
11.4 India Gene Therapy for Mucopolysaccharidosis Market Size by Application (2015-2020)

12 Central & South America
12.1 Central & South America Gene Therapy for Mucopolysaccharidosis Market Size (2015-2020)
12.2 Gene Therapy for Mucopolysaccharidosis Key Players in Central & South America (2019-2020)
12.3 Central & South America Gene Therapy for Mucopolysaccharidosis Market Size by Type (2015-2020)
12.4 Central & South America Gene Therapy for Mucopolysaccharidosis Market Size by Application (2015-2020)

13 Key Players Profiles
13.1 Sangamo Therapeutics
13.1.1 Sangamo Therapeutics Company Details
13.1.2 Sangamo Therapeutics Business Overview
13.1.3 Sangamo Therapeutics Gene Therapy for Mucopolysaccharidosis Introduction
13.1.4 Sangamo Therapeutics Revenue in Gene Therapy for Mucopolysaccharidosis Business (2015-2020))
13.1.5 Sangamo Therapeutics Recent Development
13.2 Swedish Orphan Biovitrum
13.2.1 Swedish Orphan Biovitrum Company Details
13.2.2 Swedish Orphan Biovitrum Business Overview
13.2.3 Swedish Orphan Biovitrum Gene Therapy for Mucopolysaccharidosis Introduction
13.2.4 Swedish Orphan Biovitrum Revenue in Gene Therapy for Mucopolysaccharidosis Business (2015-2020)
13.2.5 Swedish Orphan Biovitrum Recent Development
13.3 uniQure
13.3.1 uniQure Company Details
13.3.2 uniQure Business Overview
13.3.3 uniQure Gene Therapy for Mucopolysaccharidosis Introduction
13.3.4 uniQure Revenue in Gene Therapy for Mucopolysaccharidosis Business (2015-2020)
13.3.5 uniQure Recent Development

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List of Tables
Table 1. Gene Therapy for Mucopolysaccharidosis Key Market Segments
Table 2. Key Players Covered: Ranking by Gene Therapy for Mucopolysaccharidosis Revenue
Table 3. Ranking of Global Top Gene Therapy for Mucopolysaccharidosis Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Gene Therapy for Mucopolysaccharidosis Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Intravenous
Table 6. Key Players of ICV
Table 7. Key Players of Intracerebral
Table 8. Key Players of Intracisternal
Table 9. Global Gene Therapy for Mucopolysaccharidosis Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 10. Global Gene Therapy for Mucopolysaccharidosis Market Size by Regions (US$ Million): 2020 VS 2026
Table 11. Global Gene Therapy for Mucopolysaccharidosis Market Size by Regions (2015-2020) (US$ Million)
Table 12. Global Gene Therapy for Mucopolysaccharidosis Market Share by Regions (2015-2020)
Table 13. Global Gene Therapy for Mucopolysaccharidosis Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 14. Global Gene Therapy for Mucopolysaccharidosis Market Share by Regions (2021-2026)
Table 15. Market Top Trends
Table 16. Key Drivers: Impact Analysis
Table 17. Key Challenges
Table 18. Gene Therapy for Mucopolysaccharidosis Market Growth Strategy
Table 19. Main Points Interviewed from Key Gene Therapy for Mucopolysaccharidosis Players
Table 20. Global Gene Therapy for Mucopolysaccharidosis Revenue by Players (2015-2020) (Million US$)
Table 21. Global Gene Therapy for Mucopolysaccharidosis Market Share by Players (2015-2020)
Table 22. Global Top Gene Therapy for Mucopolysaccharidosis Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Gene Therapy for Mucopolysaccharidosis as of 2019)
Table 23. Global Gene Therapy for Mucopolysaccharidosis by Players Market Concentration Ratio (CR5 and HHI)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Gene Therapy for Mucopolysaccharidosis Product Solution and Service
Table 26. Date of Enter into Gene Therapy for Mucopolysaccharidosis Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Gene Therapy for Mucopolysaccharidosis Market Size by Type (2015-2020) (Million US$)
Table 29. Global Gene Therapy for Mucopolysaccharidosis Market Size Share by Type (2015-2020)
Table 30. Global Gene Therapy for Mucopolysaccharidosis Revenue Market Share by Type (2021-2026)
Table 31. Global Gene Therapy for Mucopolysaccharidosis Market Size Share by Application (2015-2020)
Table 32. Global Gene Therapy for Mucopolysaccharidosis Market Size by Application (2015-2020) (Million US$)
Table 33. Global Gene Therapy for Mucopolysaccharidosis Market Size Share by Application (2021-2026)
Table 34. North America Key Players Gene Therapy for Mucopolysaccharidosis Revenue (2019-2020) (Million US$)
Table 35. North America Key Players Gene Therapy for Mucopolysaccharidosis Market Share (2019-2020)
Table 36. North America Gene Therapy for Mucopolysaccharidosis Market Size by Type (2015-2020) (Million US$)
Table 37. North America Gene Therapy for Mucopolysaccharidosis Market Share by Type (2015-2020)
Table 38. North America Gene Therapy for Mucopolysaccharidosis Market Size by Application (2015-2020) (Million US$)
Table 39. North America Gene Therapy for Mucopolysaccharidosis Market Share by Application (2015-2020)
Table 40. Europe Key Players Gene Therapy for Mucopolysaccharidosis Revenue (2019-2020) (Million US$)
Table 41. Europe Key Players Gene Therapy for Mucopolysaccharidosis Market Share (2019-2020)
Table 42. Europe Gene Therapy for Mucopolysaccharidosis Market Size by Type (2015-2020) (Million US$)
Table 43. Europe Gene Therapy for Mucopolysaccharidosis Market Share by Type (2015-2020)
Table 44. Europe Gene Therapy for Mucopolysaccharidosis Market Size by Application (2015-2020) (Million US$)
Table 45. Europe Gene Therapy for Mucopolysaccharidosis Market Share by Application (2015-2020)
Table 46. China Key Players Gene Therapy for Mucopolysaccharidosis Revenue (2019-2020) (Million US$)
Table 47. China Key Players Gene Therapy for Mucopolysaccharidosis Market Share (2019-2020)
Table 48. China Gene Therapy for Mucopolysaccharidosis Market Size by Type (2015-2020) (Million US$)
Table 49. China Gene Therapy for Mucopolysaccharidosis Market Share by Type (2015-2020)
Table 50. China Gene Therapy for Mucopolysaccharidosis Market Size by Application (2015-2020) (Million US$)
Table 51. China Gene Therapy for Mucopolysaccharidosis Market Share by Application (2015-2020)
Table 52. Japan Key Players Gene Therapy for Mucopolysaccharidosis Revenue (2019-2020) (Million US$)
Table 53. Japan Key Players Gene Therapy for Mucopolysaccharidosis Market Share (2019-2020)
Table 54. Japan Gene Therapy for Mucopolysaccharidosis Market Size by Type (2015-2020) (Million US$)
Table 55. Japan Gene Therapy for Mucopolysaccharidosis Market Share by Type (2015-2020)
Table 56. Japan Gene Therapy for Mucopolysaccharidosis Market Size by Application (2015-2020) (Million US$)
Table 57. Japan Gene Therapy for Mucopolysaccharidosis Market Share by Application (2015-2020)
Table 58. Southeast Asia Key Players Gene Therapy for Mucopolysaccharidosis Revenue (2019-2020) (Million US$)
Table 59. Southeast Asia Key Players Gene Therapy for Mucopolysaccharidosis Market Share (2019-2020)
Table 60. Southeast Asia Gene Therapy for Mucopolysaccharidosis Market Size by Type (2015-2020) (Million US$)
Table 61. Southeast Asia Gene Therapy for Mucopolysaccharidosis Market Share by Type (2015-2020)
Table 62. Southeast Asia Gene Therapy for Mucopolysaccharidosis Market Size by Application (2015-2020) (Million US$)
Table 63. Southeast Asia Gene Therapy for Mucopolysaccharidosis Market Share by Application (2015-2020)
Table 64. India Key Players Gene Therapy for Mucopolysaccharidosis Revenue (2019-2020) (Million US$)
Table 65. India Key Players Gene Therapy for Mucopolysaccharidosis Market Share (2019-2020)
Table 66. India Gene Therapy for Mucopolysaccharidosis Market Size by Type (2015-2020) (Million US$)
Table 67. India Gene Therapy for Mucopolysaccharidosis Market Share by Type (2015-2020)
Table 68. India Gene Therapy for Mucopolysaccharidosis Market Size by Application (2015-2020) (Million US$)
Table 69. India Gene Therapy for Mucopolysaccharidosis Market Share by Application (2015-2020)
Table 70. Central & South America Key Players Gene Therapy for Mucopolysaccharidosis Revenue (2019-2020) (Million US$)
Table 71. Central & South America Key Players Gene Therapy for Mucopolysaccharidosis Market Share (2019-2020)
Table 72. Central & South America Gene Therapy for Mucopolysaccharidosis Market Size by Type (2015-2020) (Million US$)
Table 73. Central & South America Gene Therapy for Mucopolysaccharidosis Market Share by Type (2015-2020)
Table 74. Central & South America Gene Therapy for Mucopolysaccharidosis Market Size by Application (2015-2020) (Million US$)
Table 75. Central & South America Gene Therapy for Mucopolysaccharidosis Market Share by Application (2015-2020)
Table 76. Sangamo Therapeutics Company Details
Table 77. Sangamo Therapeutics Business Overview
Table 78. Sangamo Therapeutics Product
Table 79. Sangamo Therapeutics Revenue in Gene Therapy for Mucopolysaccharidosis Business (2015-2020) (Million US$)
Table 80. Sangamo Therapeutics Recent Development
Table 81. Swedish Orphan Biovitrum Company Details
Table 82. Swedish Orphan Biovitrum Business Overview
Table 83. Swedish Orphan Biovitrum Product
Table 84. Swedish Orphan Biovitrum Revenue in Gene Therapy for Mucopolysaccharidosis Business (2015-2020) (Million US$)
Table 85. Swedish Orphan Biovitrum Recent Development
Table 86. uniQure Company Details
Table 87. uniQure Business Overview
Table 88. uniQure Product
Table 89. uniQure Revenue in Gene Therapy for Mucopolysaccharidosis Business (2015-2020) (Million US$)
Table 90. uniQure Recent Development
Table 91. Research Programs/Design for This Report
Table 92. Key Data Information from Secondary Sources
Table 93. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Gene Therapy for Mucopolysaccharidosis Market Share by Type: 2020 VS 2026
Figure 2. Intravenous Features
Figure 3. ICV Features
Figure 4. Intracerebral Features
Figure 5. Intracisternal Features
Figure 6. Global Gene Therapy for Mucopolysaccharidosis Market Share by Application: 2020 VS 2026
Figure 7. Mucopolysaccharidosis I Case Studies
Figure 8. Mucopolysaccharidosis II Case Studies
Figure 9. Mucopolysaccharidosis III A Case Studies
Figure 10. Mucopolysaccharidosis III B Case Studies
Figure 11. Gene Therapy for Mucopolysaccharidosis Report Years Considered
Figure 12. Global Gene Therapy for Mucopolysaccharidosis Market Size YoY Growth 2015-2026 (US$ Million)
Figure 13. Global Gene Therapy for Mucopolysaccharidosis Market Share by Regions: 2020 VS 2026
Figure 14. Global Gene Therapy for Mucopolysaccharidosis Market Share by Regions (2021-2026)
Figure 15. Porter's Five Forces Analysis
Figure 16. Global Gene Therapy for Mucopolysaccharidosis Market Share by Players in 2019
Figure 17. Global Top Gene Therapy for Mucopolysaccharidosis Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Gene Therapy for Mucopolysaccharidosis as of 2019
Figure 18. The Top 10 and 5 Players Market Share by Gene Therapy for Mucopolysaccharidosis Revenue in 2019
Figure 19. North America Gene Therapy for Mucopolysaccharidosis Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Europe Gene Therapy for Mucopolysaccharidosis Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. China Gene Therapy for Mucopolysaccharidosis Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Japan Gene Therapy for Mucopolysaccharidosis Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Southeast Asia Gene Therapy for Mucopolysaccharidosis Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. India Gene Therapy for Mucopolysaccharidosis Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Central & South America Gene Therapy for Mucopolysaccharidosis Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Bottom-up and Top-down Approaches for This Report
Figure 27. Data Triangulation
Figure 28. Key Executives Interviewed